Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,548,017
in 9 filings, $7.5M under 10b5-1 plans

Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-14 SCHMERTZLER MICHAEL Director Sale 10b5-1 −2,118 $59.52 $126K 1,291,976
2026-10-14 SCHMERTZLER MICHAEL Director Sale 10b5-1 −382 $60.14 $23K 1,291,594
2026-10-09 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +192 $39.42 $8K 105,464
2026-10-09 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −192 $64.26 $12K 105,272
2026-10-09 Boulding Mark Elliott EXEC. VP AND CLO Option exercise · Stock Option (Right to Buy) 10b5-1 −192 2,267
2026-10-07 SCHMERTZLER MICHAEL Director Sale 10b5-1 −2,447 $63.38 $155K 1,294,147
2026-10-07 SCHMERTZLER MICHAEL Director Sale 10b5-1 −53 $63.95 $3K 1,294,094
2026-10-06 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +435 $39.42 $17K 105,707
2026-10-06 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −435 $64.16 $28K 105,272
2026-10-06 Boulding Mark Elliott EXEC. VP AND CLO Option exercise · Stock Option (Right to Buy) 10b5-1 −435 2,459
2026-10-05 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +1,638 $39.42 $65K 106,910
2026-10-05 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −1,638 $64.03 $105K 105,272
2026-10-05 Boulding Mark Elliott EXEC. VP AND CLO Option exercise · Stock Option (Right to Buy) 10b5-1 −1,638 2,894
2026-09-30 STEELE GLENN JR MD PHD Director Option exercise 10b5-1 +12,000 $11.23 $135K 34,500
2026-09-30 STEELE GLENN JR MD PHD Director Sale 10b5-1 −12,000 $65.16 $782K 22,500
2026-09-30 STEELE GLENN JR MD PHD Director Option exercise · Stock Option (Right to Buy) 10b5-1 −12,000 0
2026-09-17 SCHMERTZLER MICHAEL Director Sale 10b5-1 −9,624 $67.83 $653K 1,296,970
2026-09-17 SCHMERTZLER MICHAEL Director Sale 10b5-1 −376 $68.45 $26K 1,296,594
2026-09-16 SCHMERTZLER MICHAEL Director Sale 10b5-1 −2,994 $66.58 $199K 1,313,600
2026-09-16 SCHMERTZLER MICHAEL Director Sale 10b5-1 −7,006 $67.35 $472K 1,306,594

Page 1 of 41 · 804 trades